Advertisement

Research Summaries

Exclusive
Exclusive
05/13/2002
Researchers set out to determine whether inhibiting interleukin-13 could alleviate the most serious complication of eosinophilic esophagitis. A 16-week study yielded promising results on 4 key measures. ...
05/13/2002
Exclusive
Exclusive
05/13/2002
Researchers set out to determine whether inhibiting interleukin-13 could alleviate the most serious complication of eosinophilic esophagitis. A 16-week study yielded promising results on 4 key measures. ...
05/13/2002
Exclusive
Exclusive
05/13/2002
Researchers set out to determine whether inhibiting interleukin-13 could alleviate the most serious complication of eosinophilic esophagitis. A 16-week study yielded promising results on 4 key measures. ...
05/13/2002
Exclusive
Exclusive
12/16/2001
In this commentary, Michael J. Bloch, MD, writes about the trends in blood pressure control rates over the last 20 years and what health care providers can do to help their patients control their blood...
12/16/2001
Exclusive
Exclusive
12/04/2000
In this “Test Your Knowledge” quiz series, Melissa V. Cabellon, MD, PhD, asks you about adequate measles vaccination coverage rates to gain control of the infection.
12/04/2000
Exclusive
Exclusive
07/02/2000
In a new study, researchers investigated the relationship between the occurrence of serious infections and lymphocyte counts among patients with rheumatoid arthritis.
07/02/2000
Exclusive
Exclusive
06/01/2000
Exclusive
Exclusive
03/02/2000
The World Health Organization has subdivided lupus nephritis into 6 stages. Which of these stages is most often seen among patients with lupus who develop lupus nephritis?
03/02/2000
Exclusive
Exclusive
02/09/2000
02/09/2000